DLL4 and colonic neoplasm: Treatment of colon tumors with anti-DLL4 up-regulates markers of more differentiated colon cells (for example, ATOH1 and Chromogranin A) indicating that DLL4-Notch inhibition limits the stem/progenitor-like properties of colon tumor cells and promotes a more differentiated phenotype.